|
1
|
Zhao X and Subramanian S: Oncogenic
pathways that affect antitumor immune response and immune
checkpoint blockade therapy. Pharmacol Ther. Jul 15–2017.(Epub
ahead of print). View Article : Google Scholar
|
|
2
|
Marinelli L, Tenore GC and Novellino E:
Probiotic species in the modulation of the anticancer immune
response. Semin Cancer Biol. 46:182–190. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang A, Peng S, Farmer E, Zeng Q, Cheng
MA, Pang X, Wu TC and Hung CF: Enhancing antitumor immunogenicity
of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide
to DNA encoding capsid protein L1 of Bovine papillomavirus. Cell
Biosci. 7:462017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wein L, Savas P, Luen SJ, Virassamy B,
Salgado R and Loi S: Clinical validity and utility of
tumor-infiltrating lymphocytes in routine clinical practice for
breast cancer patients: Current and future directions. Front Oncol.
7:1562017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lan KH, Liu YC, Shih YS, Tsaid CL, Yen SH
and Lan KL: A DNA vaccine against cytotoxic T-lymphocyte associated
antigen-4 (CTLA-4) prevents tumor growth. Biochem Biophys Res
Commun. 440:222–228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cao Q, Fu A, Yang S, He X, Wang X, Zhang
X, Zhou J, Luan X, Yu W and Xue J: Leukocyte-associated
immunoglobulin-like receptor-1 expressed in epithelial ovarian
cancer cells and involved in cell proliferation and invasion.
Biochem Biophys Res Commun. 458:399–404. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hellmann MD, Friedman CF and Wolchok JD:
Combinatorial cancer immunotherapies. Adv Immunol. 130:251–277.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Steinberger P, Majdic O, Derdak SV,
Pfistershammer K, Kirchberger S, Klauser C, Zlabinger G, Pickl WF,
Stöckl J and Knapp W: Molecular characterization of human
4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J
Immunol. 172:2352–2359. 2014. View Article : Google Scholar
|
|
9
|
Yan R, Yang S, Gu A, Zhan F, He C, Qin C,
Zhang X and Feng P: Murine b7-h3 is a co-stimulatory molecule for T
cell activation. Monoclon Antib Immunodiagn Immunother. 32:395–398.
2013.PubMed/NCBI
|
|
10
|
Wang F, Wang G, Liu T, Yu G, Zhang G and
Luan X: B7-H3 was highly expressed in human primary hepatocellular
carcinoma and promoted tumor progression. Cancer invest.
32:262–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao JL, Chen FL, Zhou Q, Pan W, Wang XH,
Xu J, Zhang SX, Ni LI and Yang HL: B7-H3 protein expression in a
murine model of osteosarcoma. Oncol Lett. 12:383–386.
2016.PubMed/NCBI
|
|
12
|
Xu H, Chen X, Tao M, Chen K, Chen C, Xu G,
Li W, Yuan S and Mao Y: B7-H3 and B7-H4 are independent predictors
of a poor prognosis in patients with pancreatic cancer. Oncol Lett.
11:1841–1846. 2016.PubMed/NCBI
|
|
13
|
Wang Z, Yang J, Zhu Y, Zhu Y, Zhang B and
Zhou Y: Differential expression of 2IgB7-H3 and 4IgB7-H3 in cancer
cell lines and glioma tissues. Oncol Lett. 10:2204–2208.
2015.PubMed/NCBI
|
|
14
|
Wu D, Zhang Z, Pan H, Fan Y, Qu P and Zhou
J: Upregulation of the B7/CD28 family member B7-H3 in bladder
cancer. Oncol Lett. 9:1420–1424. 2015.PubMed/NCBI
|
|
15
|
Sun J, Mao Y, Zhang YQ, Guo YD, Mu CY, Fu
FQ and Zhang XG: Clinical significance of the induction of
macrophage differentiation by the costimulatory molecule B7-H3 in
human non-small cell lung cancer. Oncol Lett. 6:1253–1260.
2013.PubMed/NCBI
|
|
16
|
Steinberger P: B7-H3 ameliorates GVHD.
Blood. 125:3219–3221. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rusolo F, Pucci B, Colonna G, Capone F,
Guerriero E, Milone MR, Nazzaro M, Volpe MG, Di Bernardo G,
Castello G and Costantini S: Evaluation of selenite effects on
selenoproteins and cytokinome in human hepatoma cell lines.
Molecules. 18:2549–2562. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jovanovic DV, Di Battista JA,
Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F and
Pelletier JP: IL-17 stimulates the production and expression of
proinflammatory cytokines, IL-beta and TNF-alpha, by human
macrophages. J Immunol. 160:3513–3521. 1998.PubMed/NCBI
|
|
19
|
Zrioual S, Toh ML, Tournadre A, Zhou Y,
Cazalis MA, Pachot A, Miossec V and Miossec P: IL-17RA and IL-17RC
receptors are essential for IL-17A-induced ELR+ CXC
chemokine expression in synoviocytes and are overexpressed in
rheumatoid blood. J Immunol. 180:655–663. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang G, Zhou KF and Lu ZH: Interleukin-17
enhances the removal of respiratory syncytial virus in mice by
promoting neutrophil migration and reducing interferon-gamma
expression. Genet Mol Res. 15:2016.
|
|
21
|
Sanacora S, Urdinez J, Chang TP and
Vancurova I: Anticancer drug bortezomib increases interleukin-8
expression in human monocytes. Biochem Biophys Res Commun.
460:375–379. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu J, Duan Y, Cheng X, Chen X, Xie W,
Long H, Lin Z and Zhu B: IL-17 is associated with poor prognosis
and promotes angiogenesis via stimulating VEGF production of cancer
cells in colorectal carcinoma. Biochem Biophys Res Commun.
407:348–354. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chiu BL, Li CH and Chang CC: Selective
modulation of MHC class II chaperons by a novel IFN-γ-inducible
class II transactivator variant in lung adenocarcinoma A549 cells.
Biochem Biophys Res Commun. 440:190–195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang JH, Wei W, Guo ZX, Shi M and Guo RP:
Decreased Cezanne expression is associated with the progression and
poor prognosis in hepatocellular carcinoma. J Transl Med.
13:412015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang G, Xu Y, Lu X, Huang H, Zhou Y, Lu B
and Zhang X: Diagnosis value of serum B7-H3 expression in non-small
cell lung cancer. Lung Cancer. 66:245–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ching CT, Van Hieu N, Cheng TY, Fu LS, Sun
TP, Liu MY, Huang SH and Yao YD: Liver cancer detection by a
simple, inexpensive and effective immunosensor with zinc oxide
nanoparticles. Sensors (Basel). 15:29408–29418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liao R, Sun J, Wu H, Yi Y, Wang JX, He HW,
Cai XY, Zhou J, Cheng YF, Fan J and Qiu SJ: High expression of
IL-17 and IL-17RE associate with poor prognosis of hepatocellular
carcinoma. J Exp Clin Cancer Res. 32:32013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Q, Luan W, Warren L, Fiel MI, Blank
S, Kadri H, Mandeli J and Hiotis SP: Prognostic role of immune
cells in hepatitis B-associated hepatocellular carcinoma following
surgical resection depends on their localization and tumor size. J
Immunother. 39:36–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park SY, Han J, Kim JB, Yang MG, Kim YJ,
Lim HJ, An SY and Kim JH: Interleukin-8 is related to poor
chemotherapeutic response and tumourigenicity in hepatocellular
carcinoma. Eur J Cancer. 50:341–350. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tang KH, Ma S, Lee TK, Chan YP, Kwan PS,
Tong CM, Ng IO, Man K, To KF, Lai PB, et al: CD133(+) liver
tumor-initiating cells promote tumor angiogenesis, growth, and
self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
Hepatology. 55:807–820. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu B, Lin N, Zhang M, Zhu Y, Cheng H,
Chen S, Ling Y, Pan W and Xu R: Activated hepatic stellate cells
promote angiogenesis via interleukin-8 in hepatocellular carcinoma.
J Transl Med. 13:3652015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kao JT, Feng CL, Yu CJ, Tsai SM, Hsu PN,
Chen YL and Wu YY: IL-6, through p-STAT3 rather than p-STAT1,
activates hepatocarcinogenesis and affects survival of
hepatocellular carcinoma patients: A cohort study. BMC
Gastroenterol. 15:502015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sheng T, Wang B, Wang SY, Deng B, Qu L, Qi
XS, Wang XL, Deng GL and Sun X: The relationship between serum
interleukin-6 and the recurrence of hepatitis B virus related
hepatocellular carcinoma after curative resection. Medicine
(Baltimore). 94:e9412015. View Article : Google Scholar : PubMed/NCBI
|
